Use of the green fluorescent protein as a quantitative reporter of epidermal growth factor receptor-mediated gene delivery

Tissue Engineering

Volumn 3, Issue 1, 1997, Pages 53-63

  Schaffer, David V ^a   Neve, Rachael L ^b   Lauffenburger, Douglas A ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; PLASMID DNA; POLYLYSINE; STREPTAVIDIN;

AFFINITY CHROMATOGRAPHY; AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DNA TRANSFECTION; FIBROBLAST CULTURE; GENE TARGETING; GENE TRANSFER; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DNA BINDING; RECEPTOR BINDING; RECEPTOR GENE;

EID: 0030948142     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1997.3.53     Document Type: Article

References (42)

1. McKusick, V.A., ed. Mendelian Inheritance in Man. Baltimore: Johns Hopkins University Press, 1991.
2. Hirschhorn, R. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: Overview, genetic heterogeneity and therapy. Birth Defect 19, 73, 1983.
3. Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds. The Metabolic Basis of Inherited Disease, 6th ed. New York: McGraw-Hill, 1989.
4. Welsh, M.J., and Smith, A.E. Cystic fibrosis. Sci. Am. 273, 52, 1995.
5. Hodgson, C.P. The vector void in gene therapy. Bio/Technology 13, 222, 1995.
6. Marshall, E. Gene therapy's growing pains. Science 269, 1050, 1995.
7. Cotten, M., Wagner, W., and Birnstiel, M.L. Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol. 217, 618, 1993.
8. Wagner, E., Curiel, D., and Cotten, M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Deliv. Rev. 14, 113, 1994.
9. Wu, G.Y., and Wu, C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429, 1987.
10. Wu, G.Y., Zhan, P., Sze, L.L., Rosenberg, A.R., and Wu, C.H. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J. Biol. Chem. 269, 11542, 1994.
11. Plank, C., Zatloukal, K., Cotten, M., Mechlter, K., and Wagner, E. Gene transfer into hepatocytes using asialoglycoprotein receptor-mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconj. Chem. 3, 533, 1992.
12. Monsigny, M., Roche, A.C., Midoux, P., and Mayer, R. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv. Drug Deliv. Rev. 14, 1, 1994.
13. Chen, J., Gamou, S., Takayanagi, A., and Shimizu, N. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 338, 167, 1994.
14. Cotten, M., Wagner, E., Zatloukal, K., Phillips, S., Curiel, D.T., and Birnstiel, M.L. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA 89, 6094, 1992.
15. Stankovics, J., Crane, A.M., Andrews, E., Wu, C.H., Wu, G.Y., and Ledley, F.D. Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. Human Gene Ther. 5, 1095, 1994.
16. Plank, C., Oberhauser, B., Mechtler, K., Koch, C., and Wagner, E. The influence of endosome-disruptive peptide on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918, 1994.
17. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D.T., and Birnstiel, M.L. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89, 6099, 1992.
18. Mulligan, R.C. The basic science of gene therapy. Science 260, 926, 1993.
19. Kasahara, N., Dozy, A.M., and Kan, Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373, 1994.
20. Han, X., Kasahara, N., and Kan, Y.W. Ligand-directed retroviral targeting of human breast cancer cells. Proc. Natl. Acad. Sci. USA 92, 9747, 1995.
21. Engler, D.A., Matsunami, R.K., Campion, S.R., Stringer, C.D., Stevens, A., and Niyogi, S.K. Cloning of authentic human epidermal growth factor as a bacterial secretory protein and its initial structure-function analysis by sitedirected mutagenesis. J. Biol. Chem. 263, 12384, 1988.
22. Campion, S.R., Matsunami, R.K., Engler, D.A., and Niyogi, S.K. Biochemical properties of site-directed mutants of human epidermal growth factor: Importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding. Biochemistry 29, 9988, 1990.
23. Campion, S.R., Tadaki, D.K., and Niyogi, S.K. Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification. J. Cell. Biochem. 50, 35, 1992.
24. Chang, C.-P., Lazar, C.S., Walsh, B.J., Komuro, M., Collawn, J.F., Kuhn, L.A., Tainer, J.A., Trowbridge, I.S., Farquhar, M.G., Rosenfeld, M.G., Wiley, H.S., and Gill, G.N. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J. Biol. Chem. 268, 19312, 1993.
25. French, A.R., Sudlow, G.P., Wiley, H.S., and Lauffenburger, D.A. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269, 15749, 1994.
26. French, A.R., Tadaki, D.K., Niyogi, S.K., and Lauffenburger, D.A. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270, 4334, 1995.
27. Herbst, J.J., Opresko, L.K., Walsh, B.J., Lauffenburger, D.A., and Wiley, H.S. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J. Biol. Chem. 269, 12865, 1994.
28. Bothwell, M. Tissue localization of nerve growth factor and nerve growth factor receptors. Curr. Top. Microbiol. and Immunol. 165, 55, 1991.
29. Kordower, J.H., Mufson, E.J., Granholm, A.-C., Hoffer, B., and Friden, P.M. Delivery of trophic factors to the primate brain. Exp. Neurobiol. 124, 21, 1993.
30. Nicola, N.A., ed. Cytokines and Their Receptors. Oxford: Oxford University Press, 1994.
31. Schoeman, R., Joubert, D., Ariatti, M., and Hawtrey, A.O. Further studies on targeted DNA transfer to cells using a highly efficient delivery system of biotinylated transferrin and biotinylated polylysine complexed to streptavidin. J. Drug Target 2, 509, 1995.
32. Schwarzenberger, P., Spence, S.E., Gooya, J.M., Michiel, D., Curiel, D.T., Ruscetti, F.W., and Keller, J.R. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87, 472, 1996.
33. Prasher, D.C., Eckenrode, V.K., Ward, W.W., Prendergast, F.G., and Cormier, M.J. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111, 229, 1992.
34. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., and Prasher, D.C. Green fluorescent protein as a marker for gene expression. Science 263, 802, 1994.
35. Heim, R., Cubitt, A.B., and Tsien, R.Y. Improved green fluorescence. Nature 373, 663, 1995.
36. Cheng, L., Fu, J., Tsukamoto, A., and Hawley, R.G. Use of gree fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnol. 14, 606, 1996.
37. Levy, J.P., Muldoon, R.R., Zolotukhin, S., and C.J. Link Jr. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nature Biotechnol. 14, 610, 1996.
38. Wagner, E., Cotten, M., Foisner, R., and Birnstiel, M.L. Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. USA 88, 4255, 1991.
39. Erbacher, P., Roche, A.C., Monsigny, M., and Midoux, P. Glycosylated polylysine/DNA complexes: Gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconj. Chem. 6, 401, 1995.
40. Bertelsen, A.H., Beaudry, G.A., Stoller, T.J., Trotta, P.P., and Sherman, M.I. Tumor suppressor genes: Prospects for cancer therapies. Bio/Technology 13, 127, 1995.
41. Gilboa, E., and Smith, C. Gene therapy for infectious diseases: The AIDS Model. Trends Genet. 10, 139, 1994.
42. Roth, J.A. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC). Human Gene Ther. 7, 875, 1996.